Amlodipine and lisinopril in combination for the treatment of essential hypertension: Efficacy and predictors of response

Journal of Hypertension

Volumn 11, Issue 8, 1993, Pages 839-847

  Cappuccio, Francesco P ^a   Markandu, Nirmala D ^a   Singer, Donald R J ^a   MacGregor, Graham A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Amlodipine; Blood pressure; Combination therapy; Double blind crossover trial; Essential hypertension; Lisinopril; Renin angiotensin system

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ESSENTIAL HYPERTENSION; PLASMA RENIN ACTIVITY; RACE DIFFERENCE; SPHYGMOMANOMETER; ULTRASOUND;

ADULT; AMLODIPINE; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FORECASTING; HORMONES; HUMAN; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGE; SUPINE POSITION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0027199198     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199308000-00011     Document Type: Article

References (30)

1. Brouwer RML, Bolli P, Erne P, Conen D, Kiowski W, Buhler FR: Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. J Cardiovasc Pharmacol 1985,(suppl 1):S88–S91.
2. Mimran A, Ribstein J: Effect of chronic nifedipine in patients inadequately controlled by a converting enzyme inhibitor and a diuretic. J Cardiovasc Pharmacol 1985,(suppl 1):S92–S95.
3. Cappuccio FP, MacGregor GA: Combination therapy in hypertension. J Hum Hypertens 1991,(suppl 2):9–15.
4. Singer DRJ, Markandu ND, Shore AC, MacGregor GA: Captopril and nifedipine in combination for moderate to severe essential hypertension. Hypertension 1987, 9:629–633.
5. Beerman B: Pharmacokinetics of lisinopril. Am J Med 1988,(suppl 3B):25–30.
6. Herpin D, Conte D: Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring. J Hum Hypertens 1989, 3:11–15.
7. Whelton A, Miller WE, Dunne B Jr, Hait HI, Tresznewsky ON: Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures. J Clin Pharmacol 1990, 30:1074–1080.
8. Faulkner JK, McGibney D, Chausseaud LF, Perry JL, Taylor IW: The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 1986, 22:21–25.
9. Webster J, Robb OJ, Jeffers TA, Scott AK, Petrie JC, Towler HM: Once daily amlodipine in the treatment of mild to moderate hypertension. Br J Clin Pharmacol 1987, 24:713–719.
10. MacGregor GA, Rotellar C, Markandu ND, Smith SJ, Sagneija GA: Contrasting effects of nifedipine, captopril and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1982,(suppl 3):S358–S362.
11. George CF, Lewis PJ, Petrie A: Clinical experience with use of ultrasound sphygmomanometer. Br Heart J 1975, 37:804–807.
12. Roulston JE, MacGregor GA: Measurements of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta 1978, 88:45–48.
13. James VHT, Wilson GA: Assays of drugs and other trace compounds in biological fluids. In Methodological Developments in Biochemistry, vol 5. Edited by Reid E. Amsterdam: Elsevier; 1976:149–158.
14. Sagneija GA, Markandu ND, Shore AC, MacGregor GA: Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 1985, ii:1208–1211.
15. MacGregor GA, Sagnella GA, MacRae KD: Misleading paper about misleading statistics. Lancet 1985, i:926–927.
16. Weinberger MH: Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol 1985,(suppl 1):S22–S55.
17. Cappuccio FP, Markandu ND, Sagneija GA, MacGregor GA: Sodium restriction lowers blood pressure through a decreased response of the renin system. Direct evidence using saralasin. J Hypertens 1985, 3:243–247.
18. Ene HD, Williamson PJ, Roberts CJC, Waddel G: The natriuresis following oral administration of the calcium antagonists, nifedipine and nitrendipine. Br J Clin Pharmacol 1985, 19:423–427.
19. Pevahouse JB, Markandu ND, Cappuccio FP, Buckley MG, Sagneija GA, MacGregor GA: Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ 1990, 301:580–584.
20. Cappuccio FP, Markandu ND, Sagneija GA, Singer DRJ, Miller MA, Buckijiy MG, et al.: Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med 1991, 91:233–238.
21. Cappuccio FP, Markandu ND, Sagneija GA, Singer DRJ, Buckley MG, Miller MA, et al.: Effects of amlodipine on urinary sodium excretion, renin—angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens 1991, 5:115–119.
22. Singer DRJ, Markandu ND, Cappuccio FP, MacGregor GA: Moderate sodium restriction added to an angiotensin converting enzyme inhibitor is as effective in lowering blood pressure as adding a thiazide, without the adverse metabolic effects [abstract]. J Hypertens 1991,(suppl 6):S485.
23. MacGregor GA, Markandu ND, Singer DRJ, Cappuccio FP, Shore AC, Sagnella GA: Moderate sodium restriction with converting enzyme inhibitor in essential hypertension. BMJ 1987, 294:531–534.
24. Cappuccio FP, Markandu ND, Singer DRJ, MacGregor GA: ACE-inhibitors and calcium-antagonists combined with sodium restriction in essential hypertension [abstract]. Am J Hypertens 1990, 3:112A.
25. Stornello M, Dirao G, Iachello M, Pisani R, Scapellato L, Pedrinelli R, et al,: Haemodynamic and humoral interactions between captopril and nifedipine. Hypertension 1983,(suppl III):III154–III156.
26. Ajayi AA, Campbell BC, Meredith PA, Kelman AW, Reid JL: The effect of captopril on the reflex control heart rate: possible mechanisms. Br J Clin Pharmacol 1985, 20:17–25.
27. Bellet M, Sassano P, Guyenne T, Corvol P, Ménard J: Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine. Br J Clin Pharmacol 1987, 24:465–472.
28. Jacobsen J, Glaus L, Graf P, Degen P, Maurice NP, Bellet M, et al.: Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril. J Hypertens 1992, 10:1045–1051.
29. MacGregor GA, Cappuccio FP, Markandu ND: Sodium intake, high blood pressure and calcium channel blockers. Am J Med 1987,(suppl 3B):16–22.
30. Hayes RJ: Methods for assessing whether change depends on initial value. Stat Med 1988, 7:915–927.